Never heard of that drug or scandal - thanks for posting about it - I definitely think it could be the reason ARNA is getting denied in Europe, especially given the close molecular ties between B and the Mediator drug. If true, that's bad news - EMA may want to see 10 years of data to prove B doesn't hit the 2b receptor!
Market Data 
Markets 
AI
